Fortis Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Fortis Capital Advisors's VRTX Position: Q2 2026 in Review
Fortis Capital Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 20% in Q2 2026, buying an estimated $172K and bringing the position to 2,368 shares worth $1.18M. The position accounts for 0.13% of the portfolio, ranked #138.
Fortis Capital Advisors first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Fortis Capital Advisors held 2,368 shares of Vertex Pharmaceuticals worth $1.18M as of Q2 2026.
- Fortis Capital Advisors bought 388 Vertex Pharmaceuticals shares in Q2 2026, an estimated $172K.
- Vertex Pharmaceuticals made up 0.13% of Fortis Capital Advisors's portfolio in Q2 2026, its #138 holding.
- Fortis Capital Advisors first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Fortis Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.